Reem Masarwa

  • Citations Per Year
Learn More
BACKGROUND Vasopressin (AVP) and terlipressin (TP) have been used as last-line therapy in refractory shock in children. However, the efficacy and safety profiles of AVP and TP have not been determined in pediatric refractory shock of different origins. We aimed to assess the efficacy and safety of the addition of AVP/TP therapy in pediatric refractory shock(More)
into the molecular pathogenesis of LCH by identifying the BRAFV600E gain-offunction mutation. In our case, LCH tissue and bone marrow tissue were also negative for BRAF-activating somatic mutations. Therefore, we consider CML after LCH therapy not to be associated with a BRAF mutation. We could not determine whether CML in our case developed de novo or was(More)
PURPOSE Data on non-fermentative Gram-negative rods (NFGNR) bacteremia in children with malignancies are limited. The aim of this study was to present clinical picture, antimicrobial susceptibility pattern, risk factors for resistance and outcome in NFGNR bacteremia in children with cancer. METHODS All episodes of NFGNR bacteremia occurring during(More)
  • 1